Evidence map›Paper›PMID 23846195›Full record

ArticleEuropean journal of pediatrics2014

Different course of lung disease in two siblings with novel ABCA3 mutations.

Maarja Hallik, Tarmo Annilo, Mari-Liis Ilmoja

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in European journal of pediatrics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it, 22 citations in OpenAlex.

  1. Old and emerging therapies for childhood interstitial lung disease (chILD): a systematic review.European respiratory review : an official journal of the European Respiratory Society · 2026
    Pooled it
  2. Systematic review of drug effects in humans and models with surfactant-processing disease.European respiratory review : an official journal of the European Respiratory Society · 2018
    Pooled it
  3. Biallelic LAMP3 variants in 5 families with interstitial lung disease: Evidence of a disease-gene association.Genetics in medicine : official journal of the American College of Medical Genetics · 2026
    Article
  4. Article
  5. Novel Compound Heterozygous Mutation of theJournal of clinical medicine · 2025
    Article
  6. Article
  7. ABCA3 Deficiency-Variant-Specific Response to Hydroxychloroquine.International journal of molecular sciences · 2023
    Article
  8. Review
  9. Translational pediatrics · 2021
    Article
  10. [Dyspnea and ventilator dependence after birth in a full-term female infant].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2020
    Article
  11. Article
  12. Article
  13. Genotype-phenotype correlations for infants and children with ABCA3 deficiency.American journal of respiratory and critical care medicine · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Maarja HallikDepartment of Anesthesiology and Intensive Care, Clinic of Pediatrics, Tallinn Children's Hospital, Tervise 28, 13419, Tallinn, Estonia, maarja.hallik@lastehaigla.ee.
Tarmo Annilo
Mari-Liis Ilmoja
University of Tartu · EETallinn Health Care College · EE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mutations in the gene for adenosine triphosphate-binding cassette transporter subfamily A member 3 (ABCA3) have been reported in infants and children with surfactant deficiency and interstitial lung disease. We report a case of siblings found to be compound heterozygotes for two novel ABCA3 gene mutations but developing very different course of lung disease. The index case is a baby girl with severe interstitial lung disease that manifested on the first days of life. Her 4-year-old brother carrying the same mutations has no signs of lung disease so far. Our findings suggest the contribution of other genetic, epigenetic and environmental factors to discordant phenotype observed in patients carrying the same mutations in the ABCA3 gene. The clinical course of the index case suggests benefit of combined medical therapy in treating infants with ABCA3 deficiency.

Indexed as

HeterozygoteMutationPhenotypeSiblingsATP-Binding Cassette TransportersChild, PreschoolFemaleGenetic MarkersHumansInfant, NewbornLung Diseases, InterstitialMaleABCA3 protein, humanATP-Binding Cassette TransportersGenetic Markers

Identifiers

PMID23846195
OpenAlexW2089077868

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.